For: | Low EXS, Tripon E, Lim K, Tan PS, Low HC, Dan YY, Lee YM, Muthiah M, Loo WM, Koh CJ, Phyo WW, Pang J, Lim SG, Lee GH. Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection. World J Hepatol 2019; 11(6): 553-561 [PMID: 31293723 DOI: 10.4254/wjh.v11.i6.553] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v11/i6/553.htm |
Number | Citing Articles |
1 |
Antonio Rivero-Juarez, Nicolau Vallejo, Pedro Lopez-Lopez, Ana Isabel Díaz-Mareque, Mario Frias, Aldara Vallejo, Javier Caballero-Gómez, María Rodríguez-Velasco, Esther Molina, Antonio Aguilera. Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients. Microorganisms 2019; 8(1): 51 doi: 10.3390/microorganisms8010051
|
2 |
Filippo Gabrielli, Francesco Alberti, Cristina Russo, Carmela Cursaro, Hajrie Seferi, Marzia Margotti, Pietro Andreone. Treatment Options for Hepatitis A and E: A Non-Systematic Review. Viruses 2023; 15(5): 1080 doi: 10.3390/v15051080
|
3 |
George E. Markakis, George V. Papatheodoridis, Evangelos Cholongitas. Epidemiology and treatment of hepatitis E in the liver transplantation setting: A literature review. Journal of Viral Hepatitis 2022; 29(9): 698 doi: 10.1111/jvh.13709
|
4 |
Busara Songtanin, Adebayo J. Molehin, Kevin Brittan, Wuttiporn Manatsathit, Kenneth Nugent. Hepatitis E Virus Infections: Epidemiology, Genetic Diversity, and Clinical Considerations. Viruses 2023; 15(6): 1389 doi: 10.3390/v15061389
|
5 |
Zhongren Ma, Robert A. de Man, Nassim Kamar, Qiuwei Pan. Chronic hepatitis E: Advancing research and patient care. Journal of Hepatology 2022; 77(4): 1109 doi: 10.1016/j.jhep.2022.05.006
|
6 |
Myrte Gorris, Bernice M. van der Lecq, Karel J. van Erpecum, Joep de Bruijne. Treatment for chronic hepatitis E virus infection: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2021; 28(3): 454 doi: 10.1111/jvh.13456
|